The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

The task force determines which preventive services insurers must cover at no cost to patients.

In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer ...

CHITRADURGA: A woman and her husband allegedly strangled her HIV-positive brother to death as they were ashamed that his ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

The Republican-led Senate rescued funding for PEPFAR in a package of spending cuts last month, but the HIV-prevention program ...

Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...

Ending the spread of HIV in Arizona may become more difficult if federal funding is cut or eliminated. Phoenix is trying to ...

Long-acting lenacapavir has been shown to be a promising option for HIV PrEP and is now recommended globally by WHO, with a ...